Back to search

Article

Severe rhabdomyolysis associated with etoposide-nedaplatin chemotherapy in a patient with small cell lung cancer:case report and review of literature

2022-10-03

Abstract excerpt

Etoposide combined with platinum drugs is the first-line chemotherapy for small cell lung cancer(SCLC). Here, we describe the first case with small cell lung cancer, who developed severe rhabdomyolysis after etoposide-nedaplatin chemotherapy. He complained of progressive generalized muscle pain and weakness after first cycle chemotherapy for SCLC, accompanied by elevated creatine kinase (CK), myoglobin (Mb), alani...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
59963e6e-af9b-5d1b-b467-977907ba71b2
DOI
10.22541/au.166479842.25115276/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Severe rhabdomyolysis associated with etoposide-nedaplatin chemotherapy in a patient with small cell lung cancer:case report and review of literatureDOI 10.22541/au.166479842.25115276/v1
Select a neighboring publication to make it the new centre.